Table 1. Expression of RARRES3 protein in colorectal tissues.
|
RARRES3 protein levels (No. (%) of cases) |
IRSa | ||||
| Tissues | No. of cases | Negative | Weak | Strong | Mean±s.e.m. |
| Distal normal | 11 | 0 | 3 (27.3) | 8 (72.7) | 5.55±1.76 |
| Adenoma | 20 | 7.80±1.51 | |||
| Mild dysplasia | 11 | 0 | 0 | 11 (100) | |
| Moderate dysplasia | 8 | 0 | 0 | 8 (100) | |
| Severe dysplasia | 1 | 0 | 0 | 1 (100) | |
| Tumours | |||||
| Adjacent normal | 120 | 0 | 7 (5.8) | 113 (94.2) | 7.16±1.85 |
| Adenocarcinoma | 120 | ||||
| Differentiation | |||||
| Well | 41 | 1 (2.4) | 5 (12.2) | 35 (85.4) | 7.05±2.36a |
| Moderate | 68 | 14 (20.6) | 23 (33.8) | 31 (45.6) | 4.68±3.20b |
| Poor | 11 | 8 (72.7) | 2 (18.2) | 1 (9.1) | 1.36±1.96c |
| Duke's stages | |||||
| A+B | 51 | 8 (15.7) | 12 (23.5) | 31 (60.8) | 5.71±3.30 |
| C | 44 | 8 (18.2) | 11 (25.0) | 25 (56.8) | 5.23±3.16 |
| D | 25 | 7 (28.0) | 7 (28.0) | 11 (44.0) | 4.04±3.19 |
a
IRS=immunoreactive score.
The values of IRS with different superscripts are significantly different using Kruskal–Wallis test followed by Dunn's procedure, P<0.05.